Cargando…

Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS

OBJECTIVE: To explore the hypothesis that serum neurofilament light chain (sNfL) indicative of neuroaxonal damage may improve precise disease profiling with regard to cognition and neuropsychiatric symptoms, we analyzed potential associations of sNfL levels with cognitive test scores, fatigue, depre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aktas, Orhan, Renner, Alina, Huss, André, Filser, Melanie, Baetge, Sharon, Stute, Nathalie, Gasis, Marcia, Lepka, Klaudia, Goebels, Norbert, Senel, Makbule, Graf, Jonas, Enzinger, Christian, Pinter, Daniela, Antoch, Gerald, Turowski, Bernd, Hartung, Hans-Peter, Albrecht, Philipp, Otto, Markus, Tumani, Hayrettin, Penner, Iris-Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673283/ https://www.ncbi.nlm.nih.gov/pubmed/32972970 http://dx.doi.org/10.1212/NXI.0000000000000885

Ejemplares similares

Association of Retinal Layer Thickness With Cognition in Patients With Multiple Sclerosis
por: Baetge, Sharon Jean, et al.
Publicado: (2021)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
por: Huss, André, et al.
Publicado: (2020)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
por: Huss, André, et al.
Publicado: (2020)

Safety and Tolerability of Plasma Exchange and Immunoadsorption in Neuroinflammatory Diseases
por: Dorst, Johannes, et al.
Publicado: (2020)

Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report
por: Rapp, Daniel, et al.
Publicado: (2020)

Immunoadsorption and Plasma Exchange in Seropositive and Seronegative Immune-Mediated Neuropathies
por: Davies, Alexander J., et al.
Publicado: (2020)

Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study
por: Abu-Rumeileh, Samir, et al.
Publicado: (2021)

Redox Events As Modulators of Pathology and Therapy of Neuroinflammatory Diseases
por: Lepka, Klaudia, et al.
Publicado: (2016)

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
por: Senel, Makbule, et al.
Publicado: (2014)

Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases – a retrospective cross-sectional study
por: Brauchle, Felix, et al.
Publicado: (2023)

Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms
por: Baetge, Sharon Jean, et al.
Publicado: (2023)

Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections
por: Senel, Makbule, et al.
Publicado: (2020)

Differentiation of viral and autoimmune central nervous system inflammation by kynurenine pathway
por: Luo, Yi, et al.
Publicado: (2021)

The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
por: Castellazzi, Massimiliano, et al.
Publicado: (2022)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

Erratum zu: Ocrelizumab zur Behandlung der Multiplen Sklerose
por: Graf, Jonas, et al.
Publicado: (2020)

Ocrelizumab zur Behandlung der Multiplen Sklerose
por: Graf, Jonas, et al.
Publicado: (2020)

Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trial
por: Dorst, Johannes, et al.
Publicado: (2019)

Relapse-independent multiple sclerosis progression under natalizumab
por: Graf, Jonas, et al.
Publicado: (2021)

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
por: Dorst, Johannes, et al.
Publicado: (2023)

Factors influencing serum neurofilament light chain levels in normal aging
por: Koini, Marisa, et al.
Publicado: (2021)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

Association of serum neurofilament light chain levels and neuropsychiatric manifestations in systemic lupus erythematosus
por: Engel, Sinah, et al.
Publicado: (2021)

Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023)

Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation
por: Ingwersen, J., et al.
Publicado: (2016)

Case Report: A Case of Severe Clinical Deterioration in a Patient With Multiple Sclerosis
por: Breitkopf, Katharina, et al.
Publicado: (2020)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study
por: Bittner, Stefan, et al.
Publicado: (2020)

Klinische Umsetzbarkeit der kognitiven Screeningbatterie BICAMS bei Patienten mit Multipler Sklerose: Ergebnisse der Machbarkeitsstudie in Deutschland
por: Penner, Iris-Katharina, et al.
Publicado: (2021)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Comparison of neurofilament light chain results between two independent facilities
por: Sejbaek, Tobias, et al.
Publicado: (2020)

Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab
por: Harmel, Jens, et al.
Publicado: (2014)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

The TRACK-MS Test Battery: A Very Brief Tool to Track Multiple Sclerosis-Related Cognitive Impairment
por: Taranu, Daniela, et al.
Publicado: (2022)

Serum neurofilament light levels in normal aging and their association with morphologic brain changes
por: Khalil, Michael, et al.
Publicado: (2020)

Neuropsychiatric symptoms in untreated Parkinson’s disease
por: Szatmari, Szabolcs, et al.
Publicado: (2017)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oteqse5lbp4q0te6rknvb79u2m